艾美赛珠单抗治疗甲型血友病 - Suppr

Suppr

超能文献

Emicizumab in Hemophilia A.

作者信息

Kruse-Jarres Rebecca, Hay Charles R M

机构信息

University of Washington, Seattle, WA

University of Manchester, Manchester, United Kingdom.

出版信息

N Engl J Med. 2020 Feb 20;382(8):785. doi: 10.1056/NEJMc1916299.

DOI:10.1056/NEJMc1916299

PMID:32074440

Abstract

摘要

相似文献

Emicizumab in Hemophilia A.艾美赛珠单抗治疗甲型血友病

N Engl J Med. 2020 Feb 20;382(8):785. doi: 10.1056/NEJMc1916299.

Emicizumab for the prevention of bleeds in hemophilia A.依库珠单抗预防 A 型血友病出血

Expert Opin Biol Ther. 2019 Aug;19(8):753-761. doi: 10.1080/14712598.2019.1626370. Epub 2019 Jun 13.

Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance.在血友病抑制剂管理中实施依库珠单抗：应在耐受后开具依库珠单抗。

Blood Adv. 2018 Oct 23;2(20):2780-2782. doi: 10.1182/bloodadvances.2018015842.

Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.艾美赛珠单抗用于常规预防以防止甲型血友病患者出血发作。

Drugs Today (Barc). 2018 Oct;54(10):591-600. doi: 10.1358/dot.2018.54.10.2869771.

Emicizumab in Hemophilia A.艾美赛珠单抗治疗甲型血友病

N Engl J Med. 2020 Feb 20;382(8):785-786. doi: 10.1056/NEJMc1916299.

Emicizumab (Hemlibra) for subcutaneous prophylaxis in hemophilia A.艾美赛珠单抗（Hemlibra）用于A型血友病的皮下预防治疗。

Med Lett Drugs Ther. 2019 May 20;61(1572):77-79.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.艾美赛珠单抗预防治疗伴有抑制物的甲型血友病。

N Engl J Med. 2017 Nov 30;377(22):2193-4. doi: 10.1056/NEJMc1712683.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.伴有抑制物的甲型血友病患者中艾美赛珠单抗预防治疗

N Engl J Med. 2017 Nov 30;377(22):2193. doi: 10.1056/NEJMc1712683.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.艾美赛珠单抗用于预防伴有抑制物的甲型血友病。

N Engl J Med. 2017 Nov 30;377(22):2194-2195. doi: 10.1056/NEJMc1712683.

Emicizumab in Hemophilia A. Reply.用于A型血友病的艾美赛珠单抗。回复。

N Engl J Med. 2020 Feb 20;382(8):786. doi: 10.1056/NEJMc1916299.

引用本文的文献

Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.用于预防先天性 A 型或 B 型血友病患者出血的非凝血因子治疗方法。

Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD014544. doi: 10.1002/14651858.CD014544.pub2.

Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.凝血因子 VIII 在体内调节血管性血友病因子的稳态。

J Thromb Haemost. 2023 Dec;21(12):3477-3489. doi: 10.1016/j.jtha.2023.09.004. Epub 2023 Sep 17.

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.建立评估先天性血友病 A 患者死亡率的框架及其在不良事件报告数据库中的应用。

J Thromb Haemost. 2021 Jan;19 Suppl 1(Suppl 1):21-31. doi: 10.1111/jth.15186.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验